Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry
This study provides Class IV evidence that rituximab is an effective treatment for some types of AE.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Thaler, F. S., Zimmermann, L., Kammermeier, S., Strippel, C., Ringelstein, M., Kraft, A., Sühs, K.-W., Wickel, J., Geis, C., Markewitz, R., Urbanek, C., Sommer, C., Doppler, K., Penner, L., Lewerenz, J., Rössling, R., Finke, C., Prü Tags: All Immunology, Autoimmune diseases Article Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Brain | Brain Tumor | Encephalitis | Germany Health | Glioma | Neurology | Rituxan | Study